A Study to Assess the Effect of Exenatide Treatment on Mean 24-hour Heart Rate in Patients with Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002691-33

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To explore the effect of exenatide (BID) versus placebo (BID) treatment on change in mean 24-hour HR baseline to Week 12 of study drug exposure in patients with type 2 diabetes who have inadequate glycemic control with metformin alone, TZD's alone, or a combination of metformin and TZD's.


Critère d'inclusion

  • Type 2 Diabetes

Liens